Abstract
Background
Remimazolam and dexmedetomidine are commonly used as sedatives. However, the effects and safety of remimazolam alone or in combination with dexmedetomidine have not been investigated.
Aim
We sought to investigate the clinical effects of remimazolam alone or in combination with dexmedetomidine in bronchoscopy, and their influence on cognitive function.
Method
Ninety eligible patients who underwent bronchoscopy under intravenous anesthesia were randomly divided into three groups: propofol control, remimazolam, and remimazolam plus dexmedetomidine. The primary outcome was the incidence of perioperative hypoxemia. Secondary outcomes included induction and maintenance doses of remimazolam, hemodynamic variables, scores for modified Observer's Assessment of Alertness/Sedation (MOAA/S), coughing, limb movement, incidence of adverse events, patient satisfaction, bronchoscopist satisfaction, incidence of post-operative cognitive dysfunction (POCD), time to loss of consciousness (LoC), and time to awake.
Results
The incidence of hypoxemia, hypotension, and bronchoscopist satisfaction score were significantly decreased, and time to LoC and time to awake were markedly longer in the remimazolam and remimazolam plus dexmedetomidine groups than in the propofol control group (p < 0.05). The remimazolam group had significantly decreased induction and maintenance doses of remimazolam and a shorter time to LoC than the remimazolam plus dexmedetomidine group (p < 0.05). Scores for coughing, limb movement, MOAA/S, and post-operative patient satisfaction were comparable among the three groups. POCD was not induced in any of the groups.
Conclusion
Remimazolam is safe and effective for painless bronchoscopy, with a low incidence of adverse reactions, and exhibits a good synergistic effect with dexmedetomidine.
Trial Registration
This trial protocol had been registered on Chinese Clinical Trial Registry (ChiCTR2000041435, date: 2020 12 26
Similar content being viewed by others
References
Criner GJ, Eberhardt R, Fernandez-Bussy S, et al. Interventional Bronchoscopy. Am J Respir Crit Care Med. 2020;202(1):29–50.
Nelson ME. Moderate sedation changes for bronchoscopy in 2017. Chest. 2017;152(4):893–7.
McCambridge AJ, Boesch RP, Mullon JJ. Sedation in bronchoscopy: a review. Clin Chest Med. 2018;39(1):65–77.
Wang Z, Hu Z, Dai T. The comparison of propofol and midazolam for bronchoscopy: a meta-analysis of randomized controlled studies. Medicine (Baltimore). 2018;97(36):1–5.
Ho C, Hayes D Jr, Khosravi M, et al. Sedation with propofol for bronchoscopy in cystic fibrosis lung transplant recipients. Lung. 2018;196(4):435–9.
Ferguson I, Bell A, Treston G, et al. Propofol or ketofol for procedural sedation and analgesia in emergency medicine-the POKER study: a randomized double-blind clinical trial. Ann Emerg Med. 2016;68(5):574-82.e1.
Sneyd JR, Rigby-Jones AE. Remimazolam for anaesthesia or sedation. Curr Opin Anaesthesiol. 2020;33(4):506–11.
Doi M, Hirata N, Suzuki T, et al. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020;34(4):491–501.
Rex DK, Bhandari R, Desta T, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018;88(3):427-37.e6.
Pastis NJ, Yarmus LB, Schippers F, et al. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest. 2019;155(1):137–46.
Liu X, Lin S, Zhong Y, et al. Remimazolam protects against lps-induced endotoxicity improving survival of endotoxemia mice. Front Pharmacol. 2021;12: 739603.
Chadha M, Kulshrestha M, Biyani A. Anaesthesia for bronchoscopy. Indian J Anaesth. 2015;59(9):565–73.
Dang X, Hu W, Yang Z, et al. Dexmedetomidine plus sufentanil for pediatric flexible bronchoscopy: a retrospective clinical trial. Oncotarget. 2017;8(25):41256–64.
Wu SH, Lu DV, Hsu CD, et al. The effectiveness of low-dose dexmedetomidine infusion in sedative flexible bronchoscopy: a retrospective analysis. Medicina (Kaunas). 2020;56(4):1–7.
Sharma J, Purohit S, Bhatia S, et al. Awake orotracheal fibre-optic intubation: comparison of two different doses of dexmedetomidine on intubation conditions in patients undergoing cervical spine surgery. Indian J Anaesth. 2017;61(10):811–7.
Gan J, Tu Q, Miao S, et al. Effects of oxycodone applied for patient-controlled analgesia on postoperative cognitive function in elderly patients undergoing total hip arthroplasty: a randomized controlled clinical trial. Aging Clin Exp Res. 2020;32(2):329–37.
Gao Y, Kang K, Liu H, et al. Effect of dexmedetomidine and midazolam for flexible fiberoptic bronchoscopy in intensive care unit patients: a retrospective study. Medicine (Baltimore). 2017;96(25):1–6.
Xue FS, He N, Liao X, et al. Clinical assessment of awake endotracheal intubation using the lightwand technique alone in patients with difficult airways. Chin Med J (Engl). 2009;122(4):408–15.
Wahidi MM, Jain P, Jantz M, et al. American College of Chest Physicians consensus statement on the use of topical anesthesia, analgesia, and sedation during flexible bronchoscopy in adult patients. Chest. 2011;140(5):1342–50.
Noda N, Hara M, Ise S, et al. Comfort and safety of bronchoscopy performed under sedation and local anesthesia in elderly patients. Medicine (Baltimore). 2020;99(43): e22561.
Maurel V, Legrand M, Bourgeois E, et al. Sedation with remifentanil or propofol for flexible bronchoscopy: a randomised controlled trial. Eur J Anaesthesiol. 2020;37(4):333–4.
Doi M, Morita K, Takeda J, et al. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. J Anesth. 2020;34(4):543–53.
Gralnek IM, Bisschops R, Matharoo M, et al. Guidance for the implementation of a safety checklist for gastrointestinal endoscopic procedures: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) Position Statement. Endoscopy. 2022;54(2):206–10.
Lee JG, Yoo KS, Byun YJ. Continuous infusion versus intermittent bolus injection of propofol during endoscopic retrograde cholangiopancreatography. Korean J Intern Med. 2020;35(6):1338–45.
Eisenried A, Schüttler J, Lerch M, et al. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: Part II. Pharmacodynam Electroencephalogram Effects Anesthesiol. 2020;132(4):652–66.
Schüttler J, Eisenried A, Lerch M, et al. Pharmacokinetics and pharmacodynamics of Remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: Part I. Pharmacokinet Clin Pharmacodynam Anesthesiol. 2020;132(4):636–51.
Zha B, Wu Z, Xie P, et al. Supraglottic jet oxygenation and ventilation reduces desaturation during bronchoscopy under moderate to deep sedation with propofol and remifentanil: a randomised controlled clinical trial. Eur J Anaesthesiol. 2021;38(3):294–301.
Zhang H, Fang B, Zhou W. The efficacy of dexmedetomidine-remifentanil versus dexmedetomidine-propofol in children undergoing flexible bronchoscopy: a retrospective trial. Medicine (Baltimore). 2017;96(1):1–6.
Paul M, Rastogi A, Chatterje A, et al. Comparative evaluation of propofol and combination of propofol-dexmedetomidine in adjunct with topical airway anesthesia for rigid bronchoscopy: a randomized double-blinded prospective study. Ann Card Anaesth. 2021;24(1):49–55.
Abulebda K, Abu-Sultaneh S, Ahmed SS, et al. Intensivist-based deep sedation using propofol for pediatric outpatient flexible bronchoscopy. World J Crit Care Med. 2017;6(4):179–84.
Sottas CE, Anderson BJ. Dexmedetomidine: the new all-in-one drug in paediatric anaesthesia? Curr Opin Anaesthesiol. 2017;30(4):441–51.
Li H, Zhang N, Zhang K, et al. Observation of the clinical efficacy of dexmedetomidine in flexible bronchoscopy under general anesthesia: clinical case experience exchange. J Int Med Res. 2019;47(12):6215–22.
Weerink MAS, Struys M, Hannivoort LN, et al. Clinical pharmacokinetics and pharmacodynamics of Dexmedetomidine. Clin Pharmacokinet. 2017;56(8):893–913.
Lee S. Dexmedetomidine: present and future directions. Korean J Anesthesiol. 2019;72(4):323–30.
Zhang J, Liu G, Zhang F, et al. Analysis of postoperative cognitive dysfunction and influencing factors of dexmedetomidine anesthesia in elderly patients with colorectal cancer. Oncol Lett. 2019;18(3):3058–64.
Acknowledgements
None.
Funding
This study was supported by Scientific Research Foundation of comfort medicine of Shandong Province Medical Association in 2020 (No. YXH2020ZX023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gao, S., Wang, T., Cao, L. et al. Clinical effects of remimazolam alone or in combination with dexmedetomidine in patients receiving bronchoscopy and influences on postoperative cognitive function: a randomized-controlled trial. Int J Clin Pharm 45, 137–145 (2023). https://doi.org/10.1007/s11096-022-01487-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-022-01487-4